Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development

Oncogene

Volumn 22, Issue 16, 2003, Pages 2466-2477

  Halkidou, Kalipso ^a   Gnanapragasam, Vincent J ^a   Mehta, Piyush B ^a   Logan, Ian R ^a   Brady, Mark E ^a   Cook, Susan ^a   Leung, Hing Y ^a   Neal, David E ^a,b   Robson, Craig N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Co activator; CWR22 xenograft; Hormone refractory; Prostate cancer; Tip60

Indexed keywords

ANDROGEN RECEPTOR; PROTEIN TIP 60; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; RECEPTOR UPREGULATION; TUMOR BIOPSY; XENOGRAFT;

ACETYLTRANSFERASES; ANDROGENS; ANIMALS; ANTIBODIES; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; COS CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0037693192     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206342     Document Type: Article

References (46)

1. Brady ME, Ozanne DM, Gaughan L, Waite I, Cook S, Neal DE and Robson CN. (1999). J. Biol. Chem., 274, 17599-17604.
2. Brawer MK. (2000). Semin. Surg. Oncol., 18, 3-9.
3. Burkhart BA, Alcorta DA, Chiao C, Isaacs JS and Barrett JC. (1999). Exo. Cell. Res., 247, 168-175.
4. Caira F, Antonson P, Pelto-Huikko M, Treuter E and Gustafsson JA. (2000). J. Biol. Chem., 275, 5308-5317.
5. Catalona WJ. (1994). N. Engl. J. Med, 331, 996-1004.
6. Chen SL, Wang SC, Hosking B and Muscat GE (2001). Mol. Endocrinol., 15, 783-796.
7. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO and Trapman J. (1996). J. Biol. Chem., 271, 6379-6388.
8. Crawford ED. (1992). Br. J. Urol., 70, 33-38.
9. Cutress RI, Townsend PA, Bateman AC, Johnson PW, Ryder K, Barnes DM and Packham G. (2001). J. Clin. Oncol., 19, 3706-3707.
10. Gao M, Ossowski L and Ferrari AC. (1999). J. Cell Physiol., 179, 336-346.
11. Gaughan L, Brady ME, Cook S, Neal DE and Robson, CN. (2001). J. Biol. Chem., 276, 46841-46848.
12. Gaughan L, Logan IR, Cook S, Neal DE and Robson, CN. (2002). J. Biol. Chem., 277, 25904-25913.
13. Gnanapragasam VJ, Robson CN, Neal DE and Leung HY. (2002). Oncogene, 21, 5069-5080.
14. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS and Wilson EM. (2001). Cancer Res., 61, 4315-4319.
15. Horikawa I., Parker ES, Solomon GG and Barrett JC. (2001). J. Cell. Biochem., 82, 415-421.
16. Ikura, T., Ogrysko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J and Nakatani Y. (2000). Cell, 102, 463-473.
17. Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A and Jarrard DF. (2000). Cancer Res., 60, 3623-3630.
18. Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, de The H and Zelent A. (1997) Proc. Natl. Acad. Sci. USA., 94, 10255-10260.
19. Krenacs L, Harris CA, Raffeld M and Jaffe ES (1996) J. Cell. Pathol., 1, 125-136.
20. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S and Sonoo H. (2000). Clin. Cancer. Res., 6, 512-518.
21. Kurihara I, Shibata H., Suzuki T., Ando T., Kobayashi S., Hayashi M., Saito I. and Saruta T. (2000). Endocr. Res., 26, 1033-1038.
22. Lee HJ, Chun M and Kandror KV. (2001). J. Biol. Chem., 276, 16597-16600.
23. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS and Kozlowski, JM. (1995) Endocrinology, 136, 796-803.
24. Majeed A, Babb P, Kones J and Quinn M. (2000). BJU Int., 85, 1058-1062.
25. McMahon SB, Van Buskirk HA, Drugan KA, Copeland TD and Cole MD. (1998) Cell, 94, 363-374.
26. Misiti S, Schomburg L, Yen PM and Chin WW. (1998) Endocrinology, 139, 2493-2500.
27. Muller JM, Isele U., Metzger E., Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R and Schule R. (2000). EMBO J., 19, 359-369.
28. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB and Pretlow TG. (1996). Cancer Res., 56, 3042-3046.
29. Norton AJ, Jordan S and Yeomans P. (1994). J Pathol., 173, 371-379.
30. Ran Q and Pereira-Smith OM. (2000). Gene, 258, 141-146.
31. Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Janne OA, Palvimo JJ and Pestell RG. (2001). Mol. Endocrinol., 15, 797-811.
32. Shang Y, Myers M and Brown M. (2002). Mol. Cell., 9, 601-610.
33. Sheridan AM, Force T, Yoon HJ, O'Leary E, Choukroun G, Taheri MR and Bonvertre JV (2001). Mol. Cell. Biol., 21, 4470-4481.
34. Shi Y, Dones M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M and Evans RM. (2001). Genes. Dev., 15, 1140-1151.
35. Sliva D., Zhu YX, Tsai S, Kamine J and Yang YC. (1999). Biochem. Biophys. Res. Commun., 263, 149-155.
36. Soto AM, Lin TM, Sakabe K, Olea N, Damassa DA and Sonnenschein C. (1995). Oncol. Res., 7, 545-558.
37. Spector DL. (1993). Curr. Opin. Cell. Biol., 5, 442-447.
38. Swinnen JV, Esquenet M, Heynes W, Rombauts W and Verhoeven G. (1994). Mol. Cell. Endocrinol. 104, 153-162.
39. Tekur S, Lau KM, Long J, Burnstein K and Ho SM. (2001). Mol. Carcinog., 30, 1-13.
40. Thenot S, Charpin M, Bonnet S and Cavailles V. (1999). Mol. Cell Endocrinol., 156, 85-93.
41. Tsai MJ and O'Malley BW. (1994). Annu. Rev. Biochem., 63, 451-486.
42. Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM and Edgehouse NL, Pretlow TP, Bodner DR and Kursh ED. (1994). Cancer Res., 54, 6049-6052.
43. Yamamoto T and Horikoshi M. (1997). J. Biol. Chem., 272, 30595-30598.
44. Yeh S and Chang C. (1996). Proc. Natl. Acad. Sci. USA., 93, 5517-5521.
45. Young CY, Andrews PE, Montgomery BT and Tindall DJ. (1992). Biochemistry, 31, 818-824.
46. Zeng C, Kim E, Warren SL and Berget SM. (1997). EMBO J., 16, 1401-1412.